News from us and our partners

Tags

Topics

0 results

News
11 January, 2017
Pixium Vision réalise l’implantation de 10 patients avec IRIS® II, son système de vision bionique innovant à 150 électrodes, dans le cadre de son étude clinique
News
9 January, 2017
DNA Script to present at the Biotech Showcase conference in San Francisco
News
9 January, 2017
Corwave- Start-up & Co - BFM 04/01/2017
News
7 December, 2016
Lysogene Appoints David Schilansky to Board of Directors
News
6 December, 2016
Asceneuron appoints J. Michael Ryan, M.D. as Chief Medical Officer
News
24 November, 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
News
14 November, 2016
ProQR Announces Results for the Third Quarter of 2016
News
8 November, 2016
CorWave Raises $17.1 Million in Series B Financing
News
24 October, 2016
ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI
News
11 October, 2016
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
News
6 October, 2016
Asceneuron Receives Grant from The Michael J. Fox Foundation for Parkinson’s Research
News
22 September, 2016
iOmx Therapeutics raises EUR 40 million in Series A round
News
14 September, 2016
Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases
News
27 June, 2016
Rgenix Announces $33 Million Series B Financing to Develop First-in-Class Cancer Therapeutics
News
17 June, 2016
Jörn Aldag Appointed CEO of Hookipa Biotech
News
1 June, 2016
Pixium Vision receives clinical trial approval from UK Regulatory Authority for 150 electrode IRIS®II bionic vision system

Pixium Vision réalise l’implantation de 10 patients avec IRIS® II, son système de vision bionique innovant à 150 électrodes, dans le cadre de son étude clinique

DNA Script to present at the Biotech Showcase conference in San Francisco

Corwave- Start-up & Co - BFM 04/01/2017

Lysogene Appoints David Schilansky to Board of Directors

Asceneuron appoints J. Michael Ryan, M.D. as Chief Medical Officer

Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries

ProQR Announces Results for the Third Quarter of 2016

CorWave Raises $17.1 Million in Series B Financing

ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

Asceneuron Receives Grant from The Michael J. Fox Foundation for Parkinson’s Research

iOmx Therapeutics raises EUR 40 million in Series A round

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

Rgenix Announces $33 Million Series B Financing to Develop First-in-Class Cancer Therapeutics

Jörn Aldag Appointed CEO of Hookipa Biotech

Pixium Vision receives clinical trial approval from UK Regulatory Authority for 150 electrode IRIS®II bionic vision system